Skip to main
CPAH
CPAH logo

CounterPath (CPAH) Earnings Dates & Reports

CounterPath (CPAH) Most Recent Earnings

Report DateMar 11, 2020
Period EndingQ3 2020
Est. EPS$0.02
Actual EPS-$0.02
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

CounterPath (CPAH) Earnings per Share (EPS) History

Signup for full access
Browse free

CounterPath (CPAH) Latest Earnings

The value each CPAH share was expected to gain vs. the value each share gained.

CounterPath (CPAH) reported its most recent earnings on Mar 11, 2020 for Q3 2020, posting earnings per share (EPS) of -$0.02. This exceeded analysts' expectations of $0.02 by 200.00%, marking a Miss.

For comparison, CounterPath reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on 12/14/2020, with analysts projecting an EPS of $0.

CounterPath (CPAH) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2021Dec 14, 2020
$0.04
DeckReportListen
Q1 2021Sep 10, 2020
$0.04
DeckReportListen
Q4 2020Jul 20, 2020
$0.13
DeckReportListen
Q3 2020Mar 11, 2020
$0.02-$0.02-200.00%
DeckReportListen

CounterPath (CPAH) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the CounterPath’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Sep 10, 2020
Jul 20, 2020
Mar 11, 2020

CounterPath (CPAH) Earnings FAQs

CounterPath (CPAH) last reported earnings on Mar 11, 2020 for Q3 2020, posting an EPS of -$0.02, which Miss the estimate of $0.02 by 200.00%.

For Q3 2020, CounterPath (CPAH) reported an EPS of -$0.02, missing analysts' estimate of $0.02 by 200.00%.

For Q3 2020, CounterPath (CPAH) Miss expectations with an actual EPS of -$0.02 vs. an estimated EPS of $0.02.

Following the last earnings report on Mar 11, 2020, CounterPath (CPAH)'s stock price moved — from — to —.

The next CounterPath (CPAH) earnings call is scheduled for Dec. 14, 2020, where executives will discuss financial results and outlook.

CounterPath (CPAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.